Stool transplant to treat gut and immune-related conditions
Treatments studied
Part of Digestive system clinical trials.
This trial studies fecal microbiota transplantation (a stool-based treatment) to improve symptoms and safety in people with certain gut and immune conditions. It aims to see whether changing gut bacteria can help you feel better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis such as irritable bowel syndrome, ulcerative colitis, Crohn’s disease, constipation, or Clostridium difficile infection (or one of the other listed conditions
- You currently have ongoing symptoms like constipation, diarrhea, belly pain, or gas
- You can safely tolerate the stool transplant delivery method (endoscopy, colonoscopy, capsule, or a tube through the nose)
- You are not pregnant and not breastfeeding
- You do not have severe problems like major liver or kidney failure, severe heart failure, or coma/stroke
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether transplanting stool bacteria into the colon (fecal microbiota transplantation) can improve ulcerative colitis symptoms in people with active, moderate to severe disease. If you qualify, the study team will also check that it’s safe for you and that you can safely undergo a scope exam.
This study tests whether transferring stool bacteria from a healthy donor (fecal microbiota transplantation) can improve symptoms of irritable bowel syndrome (IBS). It may help by changing the gut bacteria that can influence digestion and gut discomfort.
This trial tests whether fecal microbiota transplantation (FMT) can safely and effectively treat mild to moderate ulcerative colitis over the long term. FMT involves transferring stool from a healthy donor to restore a healthy balance of gut bacteria.
This trial tests whether transferring healthy bacteria from a donor's stool (called fecal microbiota transplantation) can improve bowel problems like frequent bowel movements or trouble controlling gas or stool, which are common after rectal cancer surgery. The goal is to see if this treatment helps you feel better and improves your quality of life.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This trial studies fecal microbiota transplantation, which is transferring stool bacteria from a healthy donor to help rebalance gut microbes. If you have irritable bowel syndrome (IBS) that hasn’t improved after several standard treatments, this study may see whether it reduces your symptoms and is safe.
Hear when a new Fecal Microbiota Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.